Revenue and Profit - The company's revenue for Q1 2022 was ¥90,180,005.54, a decrease of 16.11% compared to ¥107,493,453.62 in the same period last year[3] - Net profit attributable to shareholders increased by 22.75% to ¥12,460,128.89 from ¥10,150,994.76 year-on-year[3] - The company achieved operating revenue of CNY 90.18 million, a year-on-year decrease of 16.11%[17] - The net profit attributable to shareholders increased by 22.75% to CNY 12.46 million[17] - Net profit for Q1 2022 reached CNY 12,460,165.92, representing an increase of 22.8% from CNY 10,151,077.43 in Q1 2021[26] Cash Flow - The net cash flow from operating activities was negative at -¥30,690,906.04, a decline of 326.46% compared to ¥13,552,634.07 in the previous year[3] - The cash flow statement for Q1 2022 indicates a positive cash flow from operating activities, although specific figures were not detailed in the provided content[27] - The company’s cash flow from operating activities was significantly impacted, with total cash outflow reaching 151,128,807.12 CNY, compared to 108,264,666.90 CNY in the previous year[28] - Total cash inflow from investment activities was 576,262,875.01 CNY, significantly higher than 25,551,688.15 CNY in the same period last year[28] - The net cash flow from investment activities was -7,017,953.62 CNY, compared to -4,922,061.48 CNY in the previous year[28] - Cash outflow from financing activities totaled 2,234,399.56 CNY, down from 6,690,536.25 CNY in the same quarter last year[29] Assets and Liabilities - Total assets at the end of the reporting period were ¥1,283,602,323.11, down 0.97% from ¥1,296,222,023.30 at the end of the previous year[3] - Total liabilities decreased to CNY 410,753,822.75 in Q1 2022 from CNY 435,567,987.59 in Q1 2021, reflecting a reduction of 5.7%[25] - The total equity attributable to shareholders of the parent company increased to CNY 872,847,778.76 in Q1 2022 from CNY 860,653,347.80 in Q1 2021, an increase of 1.5%[25] Investment and R&D - R&D investment reached CNY 4.89 million, accounting for 5.42% of operating revenue, an increase of 0.71% compared to the previous period[18] - Research and development expenses for Q1 2022 were CNY 4,887,559.31, slightly down from CNY 5,062,050.97 in Q1 2021[25] - Investment income surged by 20,336.29% to ¥4,848,123.03 from ¥23,723.11 year-on-year, primarily due to cash management returns[9] Shareholder Information - The number of common shareholders at the end of the reporting period was 10,170[14] - The top shareholder, Sun Wenqiang, holds 31.33% of the shares, totaling 20,049,551 shares[14] Other Financial Metrics - Basic earnings per share decreased by 7.94% to ¥0.1947 from ¥0.2115 in the same period last year[3] - The weighted average return on equity decreased to 1.44% from 2.87% in the previous year, reflecting a decline of 1.43%[3] - Cash and cash equivalents decreased to CNY 267.98 million from CNY 323.45 million[22] - Inventory increased to CNY 316.68 million from CNY 280.44 million, indicating a rise in stock levels[23] - The company reported a financial expense of CNY 1,902,557.01 in Q1 2022, significantly reduced from CNY 5,618,431.15 in the same period last year[25] Government Support and Social Responsibility - The company received government subsidies amounting to ¥1,424,133.21, an increase of 105.50% compared to ¥692,994.13 in the previous year[9] - The company actively participated in social responsibility initiatives during the local pandemic, contributing approximately CNY 20,000 in supplies[20]
海泰科(301022) - 2022 Q1 - 季度财报